Z-0671-2019 Class II Terminated

Recalled by Tosoh Bioscience Inc — Grove City, OH

FDA device recall Z-0671-2019 was initiated by Tosoh Bioscience Inc on Nov 30, 2018 and is designated Class II. Reason for recall: Potential for fluorescein interference to cause inaccurately elevated results for certain Tosoh AIA assays The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 29645 units.

Recall details

Product Type
Devices
Report Date
Jan 2, 2019
Initiation Date
Nov 30, 2018
Termination Date
Jan 14, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29645 units

Product description

AIA-PACK B12 (Vitamin B12) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of vitamin B12 (B12) in human serum on Tosoh AIA System analyzers.

Reason for recall

Potential for fluorescein interference to cause inaccurately elevated results for certain Tosoh AIA assays

Distribution pattern

US Nationwide

Code information

all lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0671-2019
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Tosoh Bioscience Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0671-2019. Report a data issue: hello@regdatalab.com.